Insulet Corp (PODD):企業の財務・戦略的SWOT分析

◆英語タイトル:Insulet Corp (PODD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME7738FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Insulet Corp (PODD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetics. Omnipod system consists of a disposable self-adhesive tubeless insulin infusion device, OmniPod, and a handheld wireless device, Personal Diabetes Manager. The company also works in partnership with biotechnology and pharmaceutical companies that utilize the customized form of its Omnipod system to deliver drugs at specified intervals of time at predetermined doses. The company markets and sells its products directly and through distribution partners in North America, Asia and Europe. Insulet is headquartered in Acton, Massachusetts, the US.

Insulet Corp Key Recent Developments

Feb 23,2021: Insulet reports full year 2020 revenue increase of 23% and fourth quarter 2020 revenue increase of 18% year-over-year
Nov 04,2020: Insulet reports third quarter 2020 revenue increase of 22% year-over-year
Oct 20,2020: Insulet appoints Wayne A. I. Frederick, M.D., to Board of Directors
Oct 20,2020: Insulet appoints Wayne A. I. Frederick, M.D., to Board of Directors
Aug 06,2020: Insulet reports second quarter 2020 revenue increase of 28% year-over-year

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Insulet Corp – Key Facts
Insulet Corp – Key Employees
Insulet Corp – Key Employee Biographies
Insulet Corp – Major Products and Services
Insulet Corp – History
Insulet Corp – Company Statement
Insulet Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Insulet Corp – Business Description
Business Segment: Drug Delivery
Performance
Business Segment: International Omnipod
Performance
Business Segment: US Omnipod
Performance
Geographical Segment: All other
Performance
Geographical Segment: United States
Performance
R&D Overview
Insulet Corp – Corporate Strategy
Insulet Corp – SWOT Analysis
SWOT Analysis – Overview
Insulet Corp – Strengths
Insulet Corp – Weaknesses
Insulet Corp – Opportunities
Insulet Corp – Threats
Insulet Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Insulet Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Insulet Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Insulet Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 23, 2021: Insulet reports full year 2020 revenue increase of 23% and fourth quarter 2020 revenue increase of 18% year-over-year
Nov 04, 2020: Insulet reports third quarter 2020 revenue increase of 22% year-over-year
Oct 20, 2020: Insulet appoints Wayne A. I. Frederick, M.D., to Board of Directors
Oct 20, 2020: Insulet appoints Wayne A. I. Frederick, M.D., to Board of Directors
Aug 06, 2020: Insulet reports second quarter 2020 revenue increase of 28% year-over-year
Jun 24, 2020: Insulet installs solar panels at its global headquarters and U.S. manufacturing facility to help reduce its carbon footprint
May 07, 2020: Insulet reports first quarter 2020 revenue increase of 24% Year-Over-Year
Apr 16, 2020: Insulet expands its U.S. financial assistance program for current users impacted by COVID-19
Feb 25, 2020: Insulet reports full year 2019 revenue of $738.2 million, an increase of 31%, and fourth quarter 2019 revenue of $209.4 million, an increase of 27% year-over-year
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Insulet Corp, Key Facts
Insulet Corp, Key Employees
Insulet Corp, Key Employee Biographies
Insulet Corp, Major Products and Services
Insulet Corp, History
Insulet Corp, Other Locations
Insulet Corp, Subsidiaries
Insulet Corp, Key Competitors
Insulet Corp, Ratios based on current share price
Insulet Corp, Annual Ratios
Insulet Corp, Annual Ratios (Cont...1)
Insulet Corp, Annual Ratios (Cont...2)
Insulet Corp, Interim Ratios
Insulet Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Insulet Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Insulet Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Insulet Corp (PODD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CryoLife Inc (CRY)-医療機器分野:企業M&A・提携分析
    Summary CryoLife Inc (CryoLife) is a provider of biosurgical devices and implantable living tissues for cardiac and vascular surgical procedures. The company’s portfolio encompasses preserved human cardiac allografts, vascular allografts, surgical adhesives and sealants, heart valves, carbon dioxide …
  • Composites Technology Research Malaysia Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Composites Technology Research Malaysia Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • CorMedix Inc (CRMD):製薬・医療:M&Aディール及び事業提携情報
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • Dynegy Inc.:企業の戦略・SWOT・財務情報
    Dynegy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dynegy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Domtar Corp (UFS):企業の財務・戦略的SWOT分析
    Domtar Corp (UFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BASF SE (BAS):電力:M&Aディール及び事業提携情報
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Spark Infrastructure Group:企業の発電所・SWOT分析2018
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Cobb Electric Membership Corporation:企業の発電所・SWOT分析2018
    Cobb Electric Membership Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • NicOx SA (COX)-医療機器分野:企業M&A・提携分析
    Summary NicOx SA (NicOx) is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company offers ophthalmic products which include AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NO-donors and Syk and JAK inhibitors, and others. It offers p …
  • Vermillion Inc (VRML):医療機器:M&Aディール及び事業提携情報
    Summary Vermillion Inc (Vermillion) is a medical device company that discovers, develops and markets diagnostic and bio-analytical solutions that supports physicians to diagnose, treat and improve gynecologic health outcomes for women. The company’s in vitro diagnostic test OVA1, a simple blood test …
  • Trusted Media Brands, Inc.:企業の戦略的SWOT分析
    Trusted Media Brands, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • European Institute of Oncology-製薬・医療分野:企業M&A・提携分析
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • ERGO Life Insurance SE:企業の戦略・SWOT・財務情報
    ERGO Life Insurance SE - Strategy, SWOT and Corporate Finance Report Summary ERGO Life Insurance SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Public Financial Holdings Ltd (626):企業の財務・戦略的SWOT分析
    Public Financial Holdings Ltd (626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Imperial College London-医療機器分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • American Axle & Manufacturing Holdings Inc (AXL):企業の財務・戦略的SWOT分析
    American Axle & Manufacturing Holdings Inc (AXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Pacific Biosciences of California Inc (PACB):企業の財務・戦略的SWOT分析
    Pacific Biosciences of California Inc (PACB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆